Find Faculty
Navneet Dogra, PhD
img_Navneet Dogra
ASSISTANT PROFESSOR | Pathology, Molecular and Cell Based Medicine
ASSISTANT PROFESSOR | Artificial Intelligence and Human Health
email
Research Topics
Anti-Tumor Therapy, Biochemistry, Biomedical Informatics, Biomedical Sciences, Blood-Brain Barrier, Brain, Cancer, Cancer Genetics, Cell Biology, Clinical Genomics, Gene Discovery, Gene Expressions, Gene Therapy, Genetics, Genomics, Imaging, Membranes, Nanotechnology, Oncogenes, Parkinson's Disease, Pathology, Prostate, Protein Trafficking & Sorting, RNA, RNA Transport & Localization, Signal Transduction, Spectroscopy, Tissue Engineering, Trafficking, Tumor Suppressor Genes, Tumorigenesis, Viruses and Virology
Liquid-Biopsy in Cancer
Can we detect cancer biomarkers present in bodily fluids and avoid unnecessary surgical procedures? To answer this question, my research is focused on developing new liquid biopsy methods using circulating exosomes and extracellular vesicles, microfluidics, and next-gen genomic technologies.
Drug and Gene Delivery
Exosomes and other bio-nanoparticles for gene and drug delivery.
Exosomes and other Extracellular Vesicles
nanovesicles used for diagnostics, therapy, and bioengineering

Bachelor's of Science, Himachal Pradesh University

Doctorate, Southern Illinois University Carbondale

Master's of Science, Guru Nanak Dev University

Post Doctoral Fellow, IBM Watson Research Center

Post Doctoral Fellow, Yale University

2020

Mount Sinai Alzheimer's Disease Research Center (ADRC) Scholar.

Icahn School of Medicine at Mount Sinai Hospital

2019

Outstanding Technical Achievement Award

IBM Watson Research Center

2016

“5 in 5” groundbreaking research award

IBM Watson Research Center

2015

Yale Young Global Scholars Program, Falling Walls Finalist

Yale University

2013

Dissertation research award

Graduate School

2013

Gower Research Fellow

Graduate School

29
Publications

Selected Publications

Extracellular vesicles, RNA sequencing, and bioinformatic analyses: Challenges, solutions, and recommendations. Rebecca T. Miceli, Tzu Yi Chen, Yohei Nose, Swapnil Tichkule, Briana Brown, John F. Fullard, Marilyn D. Saulsbury, Simon O. Heyliger, Sacha Gnjatic, Natasha Kyprianou, Carlos Cordon-Cardo, Susmita Sahoo, Emanuela Taioli, Panos Roussos, Gustavo Stolovitzky, Edgar Gonzalez-Kozlova, Navneet Dogra. Journal of Extracellular Vesicles

Kinesin Facilitates Phenotypic Targeting of Therapeutic Resistance in Advanced Prostate Cancer. Maddison Archer, Diane Begemann, Edgar Gonzalez-Kozlova, Prerna R. Nepali, Estefania Labanca, Peter Shepherd, Navneet Dogra, Nora Navone, Natasha Kyprianou. Molecular Cancer Research

Expression of the αVβ3 integrin affects prostate cancer sEV cargo and density and promotes sEV pro-tumorigenic activity in vivo through a GPI-anchored receptor, NgR2. Cecilia E. Verrillo, Fabio Quaglia, Christopher D. Shields, Stephen Lin, Andrew V. Kossenkov, Hsin Yao Tang, David Speicher, Nicole M. Naranjo, Anna Testa, William K. Kelly, Qin Liu, Benjamin Leiby, Luca Musante, Khalid Sossey-Alaoui, Navneet Dogra, Tzu Yi Chen, Dario C. Altieri, Lucia R. Languino. Journal of Extracellular Vesicles

View All Publications

Exosomes & EVs: Isolation, Characterization, Machine Learning for RNA diagnostics by Navneet Dogra

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Dogra has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.